α-Ketoglutarate inhibits autophagy.


Journal

Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617

Informations de publication

Date de publication:
07 06 2019
Historique:
received: 15 04 2019
accepted: 24 05 2019
pubmed: 8 6 2019
medline: 14 7 2020
entrez: 8 6 2019
Statut: ppublish

Résumé

The metabolite α-ketoglutarate is membrane-impermeable, meaning that it is usually added to cells in the form of esters such as dimethyl -ketoglutarate (DMKG), trifluoromethylbenzyl α-ketoglutarate (TFMKG) and octyl α-ketoglutarate (O-KG). Once these compounds cross the plasma membrane, they are hydrolyzed by esterases to generate α-ketoglutarate, which remains trapped within cells. Here, we systematically compared DMKG, TFMKG and O-KG for their metabolic and functional effects. All three compounds similarly increased the intracellular levels of α-ketoglutarate, yet each of them had multiple effects on other metabolites that were not shared among the three agents, as determined by mass spectrometric metabolomics. While all three compounds reduced autophagy induced by culture in nutrient-free conditions, TFMKG and O-KG (but not DMKG) caused an increase in baseline autophagy in cells cultured in complete medium. O-KG (but neither DMKG nor TFMK) inhibited oxidative phosphorylation and exhibited cellular toxicity. Altogether, these results support the idea that intracellular α-ketoglutarate inhibits starvation-induced autophagy and that it has no direct respiration-inhibitory effect.

Identifiants

pubmed: 31173576
pii: 102001
doi: 10.18632/aging.102001
pmc: PMC6594794
doi:

Substances chimiques

Ketoglutaric Acids 0
dimethyl alpha-ketoglutarate 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3418-3431

Subventions

Organisme : Austrian Science Fund FWF
ID : W 1226
Pays : Austria

Références

Autophagy. 2010 Jan;6(1):160-2
pubmed: 20110777
Nat Rev Drug Discov. 2014 Oct;13(10):727-40
pubmed: 25212602
Mol Cell Biol. 2007 May;27(9):3282-9
pubmed: 17325041
Nat Rev Mol Cell Biol. 2018 Jun;19(6):349-364
pubmed: 29618831
Mol Cell. 2014 Mar 6;53(5):710-25
pubmed: 24560926
J Exp Med. 1995 Aug 1;182(2):367-77
pubmed: 7629499
Nat Rev Drug Discov. 2013 Nov;12(11):829-46
pubmed: 24113830
Cell Metab. 2015 Jun 2;21(6):805-21
pubmed: 26039447
Biochem J. 1940 Mar;34(3):442-59
pubmed: 16747180
Nat Commun. 2019 Feb 19;10(1):651
pubmed: 30783116
J Clin Invest. 2015 Jan;125(1):85-93
pubmed: 25654554
Oncoimmunology. 2018 Oct 1;8(1):e1498285
pubmed: 30546941
J Biol Chem. 2002 Aug 23;277(34):30409-12
pubmed: 12087111
Annu Rev Genet. 2009;43:67-93
pubmed: 19653858
Nature. 2014 Jun 19;510(7505):397-401
pubmed: 24828042
Cell. 2019 Jan 10;176(1-2):11-42
pubmed: 30633901
Physiol Rev. 2007 Jan;87(1):99-163
pubmed: 17237344
Autophagy. 2014 May;10(5):930-2
pubmed: 24675140
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Cell. 2011 Sep 2;146(5):682-95
pubmed: 21884931
Sci Rep. 2016 Aug 01;6:30767
pubmed: 27477484
Nat Med. 2000 May;6(5):513-9
pubmed: 10802706
PLoS One. 2014 Nov 24;9(11):e113865
pubmed: 25420025
Annu Rev Biochem. 2016 Jun 2;85:685-713
pubmed: 26865532
Sci Rep. 2016 May 26;6:26802
pubmed: 27225984
Immunol Lett. 1998 Apr;61(2-3):157-63
pubmed: 9657269
Cell Metab. 2015 Sep 1;22(3):508-15
pubmed: 26190651
Oncogene. 2013 Sep 19;32(38):4549-56
pubmed: 23085753
Mol Cell Biol. 2005 Feb;25(3):1025-40
pubmed: 15657430
Autophagy. 2009 Aug;5(6):847-9
pubmed: 19458476
Ageing Res Rev. 2018 Nov;47:183-197
pubmed: 30172870
Methods Enzymol. 2017;588:367-394
pubmed: 28237110
J Clin Invest. 2015 Jan;125(1):25-32
pubmed: 25654547
Science. 2018 Jan 26;359(6374):
pubmed: 29371440
PLoS One. 2013;8(7):e69720
pubmed: 23894530
Science. 2004 Jul 30;305(5684):626-9
pubmed: 15286356
Nat Cell Biol. 2009 Nov;11(11):1305-14
pubmed: 19801973
Nat Med. 2016 Dec;22(12):1428-1438
pubmed: 27841876
Biochem Biophys Res Commun. 2016 Dec 2;481(1-2):90-96
pubmed: 27823933

Auteurs

Elisa Elena Baracco (EE)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Descartes, Université Paris Diderot, "Metabolism, Cancer and Immunity", Paris 75006, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.

Francesca Castoldi (F)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Descartes, Université Paris Diderot, "Metabolism, Cancer and Immunity", Paris 75006, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.

Sylvère Durand (S)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Descartes, Université Paris Diderot, "Metabolism, Cancer and Immunity", Paris 75006, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.

David P Enot (DP)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Descartes, Université Paris Diderot, "Metabolism, Cancer and Immunity", Paris 75006, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.

Jelena Tadic (J)

Institute of Molecular Biosciences, University of Graz, NAWI Graz, Graz, Austria.

Katharina Kainz (K)

Institute of Molecular Biosciences, University of Graz, NAWI Graz, Graz, Austria.
Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Frank Madeo (F)

Institute of Molecular Biosciences, University of Graz, NAWI Graz, Graz, Austria.
BioTechMed Graz, Graz, Austria.

Alexis Chery (A)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Descartes, Université Paris Diderot, "Metabolism, Cancer and Immunity", Paris 75006, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.

Valentina Izzo (V)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Descartes, Université Paris Diderot, "Metabolism, Cancer and Immunity", Paris 75006, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.

Maria Chiara Maiuri (MC)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Descartes, Université Paris Diderot, "Metabolism, Cancer and Immunity", Paris 75006, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.

Federico Pietrocola (F)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Descartes, Université Paris Diderot, "Metabolism, Cancer and Immunity", Paris 75006, France.
Institute for Research in Biomedicine, Barcelona, Spain.

Guido Kroemer (G)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Descartes, Université Paris Diderot, "Metabolism, Cancer and Immunity", Paris 75006, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH